AVALO THERAPEUTICS INC
AVTX·05338F306·US·Common Stock·Healthcare - Biotechnology-13D/G
AVTX (AVALO THERAPEUTICS INC) is held by 54 institutional investors as of Q1 2026. Largest holders: FMR LLC ($43M), Avoro Capital Advisors LLC ($21.1M), UBS Group AG ($17M). Net institutional sentiment: Mixed.
54
Holders
Avg rating(8 Elite)
$256.6M
Total Value
64% (62)
Fund Consensus
38 buying - 21 selling
Who's Trading
InsiderDMDoyle MittieSell $93KJun 30, 2026
InsiderDMDoyle MittieSell $26KJun 23, 2026
ActivistCOCommodore Capital LP9.9%Jun 18, 2026
ActivistDTDeep Track Capital, LP5.8%May 29, 2026
InsiderDMDoyle MittieSell $11KMay 28, 2026
InsiderSRSullivan Christopher RyanExercise 19K shMay 7, 2026
13F: Insider & Congress:
Showing 1-20 of 62
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer